![Xin Hua Meng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xin Hua Meng
Vorstandsvorsitzender bei XinYu Pharmaceutical Co., Ltd.
Aktive Positionen von Xin Hua Meng
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Vorstandsvorsitzender | 01.04.2000 | - |
Vorsitzender | 01.04.2000 | - |
Karriereverlauf von Xin Hua Meng
Statistik
International
China | 2 |
Operativ
Chief Executive Officer | 1 |
Chairman | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Börse
- Insiders
- Xin Hua Meng
- Erfahrung